siltuximab (100) (62)

Structure

Heavy chain / Chaone lourde / Cadena pesada

EVQLVESGGK LLKPGGSLKL SCAASGFTFS SFAMSWFRQS PEKRLEWVAE   50

ISSGGSYTYY PDTVTGRFTI SRDNAKNTLY LEMSSLRSED TAMYYCARGL  100

WGYYALDYWG QGTSVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD  150

YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY  200

ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK  250

DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS  300

TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV  350

YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL  400

DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK   449

Light chain / Chaone lygire / Cadena ligera

QIVLIQSPAI MSASPGEKVT MTCSASSSVS YMYWYQQKPG SSPRLLIYDT   50

SNLASGVPVR FSGSGSGTSY SLTISRMEAE DAATYYCQQW SGYPYTFGGG  100

TKLEIKRTVA APSVFIFPPS DEQLKSGTAS VVCLLNNFYP REAKVQWKVD  150

NALQSGNSQE SVTEQDSKDS TYSLSSTLTL SKADYEKHKV YACEVTHQGL  200

SSPVTKSFNR GEC                                          213

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	146-202	263-323	369-427

	22??-96??	146??-202??	263??-323??	369??-427??

Intra-L	23?-87?	133?-193?



	23???-87???	133???-193???



Inter-H-L	222-213?	222??-213???



Inter-H-H	228-228??	231-231??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

299, 299??

Molecular formula	C6450H9932N1688O2016S50

Description

immunoglobulin G1-kappa, anti-[Homo sapiens interleukin 6 (IL6, IL-6)],
chimeric monoclonal antibody;

gamma1 heavy chain (1-449) [Mus musculus VH (IGHV5-9-4*01
-(IGHD)-IGHJ4*01) [8.8.12] (1-119) -Homo sapiens IGHG1*01 (120-449)],
(222-213?)-disulfide with kappa light chain (1?-213?) [Mus musculus
V-KAPPA (IGKV4-55*01 -IGKJ2*01) [5.3.9] (1?-106?) -Homo sapiens IGKC*01
(107?-213?)]; (228-228??:231-231??)-bisdisulfide dimer 

	

WHO 

International Nonproprietary Names Programme	

9051 

December 2008

Page 1/1

		

